반다 파마슈티컬스(Vanda Pharmaceuticals)
DE ˙ DB ˙ US9216591084
€5.26 ↑0.09 (1.74%)
2026-06-05
주가
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionMarshall Wace, Llp
Latest Disclosed Ownership596,002 shares
Latest Disclosed Value $ 4,118,375
Marshall Wace, Llp ownership in VM4 / Vanda Pharmaceuticals Inc.

On May 14, 2026 - Marshall Wace, Llp filed a 13F-HR form disclosing ownership of 596,002 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $3,427,012 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 0 shares of Vanda Pharmaceuticals Inc.. The current value of the position is $3,134,971 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 596,002 596,002 4,118 0.0019
2026-02-13 2025-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 -581,247 -100.00 0 -100.00
2025-11-13 2025-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 581,247 109,527 23.22 2,900 30.28 0.0029
2025-08-13 2025-06-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 471,720 426,620 945.94 2,227 975.36 0.0025
2025-05-15 2025-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 45,100 -35,700 -44.18 207 -46.51 0.0003
2025-02-13 2024-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 80,800 80,800 387 0.0005
2024-11-14 2024-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 -24,504 -100.00 0 -100.00
2024-08-14 2024-06-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 24,504 -42,141 -63.23 138 -49.45 0.0002
2024-05-15 2024-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 66,645 -120,852 -64.46 274 -65.49 0.0004
2024-02-14 2023-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 187,497 187,497 791 0.0013
2022-11-14 2022-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 -12,818 -100.00 0 -100.00
2022-08-15 2022-06-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 12,818 -3,846 -23.08 140 -25.93 0.0003
2022-05-16 2022-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 16,664 16,664 189 0.0004
2021-05-17 2021-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 -121,010 -100.00 0 -100.00
2021-02-16 2020-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 121,010 -153,844 -55.97 1,590 -40.11 0.0086
2020-11-16 2020-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 274,854 174,061 172.69 2,655 130.27 0.0170
2020-08-13 2020-06-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 100,793 -546,667 -84.43 1,153 -82.81 0.0081
2020-05-15 2020-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 647,460 185,769 40.24 6,708 -11.46 0.0670
2020-02-14 2019-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 461,691 4,546 0.99 7,576 24.79 0.0521
2019-11-14 2019-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 457,145 405,975 793.38 6,071 742.02 0.0477
2019-08-14 2019-06-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 51,170 51,156 365,400.00 721 0.0059
2019-05-29 2019-03-31 13F/A-1 VANDA PHARMACEUT COMMON STOCK 921659108 14 14 0 0.0000
2019-05-14 2019-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 14 14 0
2019-02-14 2018-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 -86,835 -100.00 0 -100.00
2018-12-06 2018-09-30 13F/A-1 VANDA PHARMACEUT COMMON STOCK 921659108 86,835 86,835 1,993 0.0170
2018-11-14 2018-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 86,835 86,835 1,993
2016-02-10 2015-12-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 0 0 0.0000
2015-11-12 2015-09-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 0 -59,233 -100.00 0 -100.00
2015-08-14 2015-06-30 13F VANDA PHARMACEUT COMMON STOCK 921659108 59,233 46,209 354.80 752 521.49 0.0098
2015-05-11 2015-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 13,024 -157,080 -92.34 121 -95.62 0.0016
2014-05-14 2014-03-31 13F VANDA PHARMACEUT COMMON STOCK 921659108 170,104 170,104 2,764 0.0503
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.